Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting.

Saved in:
Bibliographic Details
Title: Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting.
Authors: Tsugitomi R; Department of Thoracic Medical Oncology, the Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Takagi K; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: kent.takagi@chiba-u.jp., Saito G; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan., Tachihara M; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan., Ashinuma H; Division of Respiratory Medicine, Chiba Cancer Center, Chiba, Japan., Shukuya T; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan., Takemoto S; Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., Sakata S; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan., Mouri A; Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Hidaka, Japan., Miwa H; Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan., Tamura Y; Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan., Tokito T; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan., Tsukita Y; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan., Kogure Y; Department of Respiratory Medicine, NHO Nagoya Medical Center, Nagoya, Japan., Masuda T; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan., Tanaka H; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan., Kubo S; Yokohama City University Medical Center, Yokohama, Japan., Sasaki T; Department of Internal Medicine, Division of Respiratory Medicine and Neurology, Asahikawa Medical University, Asahikawa, Japan., Oba T; Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan., Mamesaya N; Division of Thoracic Oncology, Shizuoka Cancer Center, Sunto-gun, Japan., Yamanaka T; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan., Nagashima H; Division of Pulmonary Medicine, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kanemura H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan., Tozuka T; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Furuta M; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan., Kawachi H; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Ninomiya T; Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan., Nagai Y; Department of Respiratory Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Ogino H; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan., Ito K; Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan., Ishihara M; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan., Suzuki T; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Apr; Vol. 214, pp. 109309. Date of Electronic Publication: 2026 Feb 07.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-8332
DOI:10.1016/j.lungcan.2026.109309